BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11517417)

  • 1. The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.
    Cinque P; Pierotti C; Viganò MG; Bestetti A; Fausti C; Bertelli D; Lazzarin A
    J Neurovirol; 2001 Aug; 7(4):358-63. PubMed ID: 11517417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring.
    Gasnault J; Kousignian P; Kahraman M; Rahoiljaon J; Matheron S; Delfraissy JF; Taoufik Y
    J Neurovirol; 2001 Aug; 7(4):375-81. PubMed ID: 11517420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study.
    De Luca A; Giancola ML; Ammassari A; Grisetti S; Cingolani A; Larussa D; Alba L; Murri R; Ippolito G; Cauda R; Monforte A; Antinori A
    J Neurovirol; 2001 Aug; 7(4):364-8. PubMed ID: 11517418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive multifocal leukoencephalopathy treated with cidofovir in HIV-infected patients receiving highly active anti-retroviral therapy.
    Portilla J; Boix V; Román F; Reus S; Merino E
    J Infect; 2000 Sep; 41(2):182-4. PubMed ID: 11023768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy.
    Razonable RR; Aksamit AJ; Wright AJ; Wilson JW
    Mayo Clin Proc; 2001 Nov; 76(11):1171-5. PubMed ID: 11702907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy.
    Gasnault J; Taoufik Y; Goujard C; Kousignian P; Abbed K; Boue F; Dussaix E; Delfraissy JF
    J Neurovirol; 1999 Aug; 5(4):421-9. PubMed ID: 10463864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death.
    Wyen C; Hoffmann C; Schmeisser N; Wöhrmann A; Qurishi N; Rockstroh J; Esser S; Rieke A; Ross B; Lorenzen T; Schmitz K; Stenzel W; Salzberger B; Fätkenheuer G
    J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1263-8. PubMed ID: 15385733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy.
    De Luca A; Giancola ML; Ammassari A; Grisetti S; Cingolani A; Paglia MG; Govoni A; Murri R; Testa L; Monforte AD; Antinori A
    AIDS; 2000 Sep; 14(14):F117-21. PubMed ID: 11061646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of aids related PML with HAART and cidofovir.
    Zimmermann T; Stingele K; Hartmann M; Haas J; von Einsiedel R; Wildemann B
    Eur J Med Res; 2001 May; 6(5):190-62. PubMed ID: 11410399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cidofovir added to highly active antiretroviral therapy in AIDS-associated progressive multifocal leukoencephalopathy.
    Herrero-Romero M; Cordero E; López-Cortés LF; de Alarcón A; Pachón J
    AIDS; 2001 Apr; 15(6):809. PubMed ID: 11371702
    [No Abstract]   [Full Text] [Related]  

  • 11. Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy.
    Kraemer C; Evers S; Nolting T; Arendt G; Husstedt IW
    J Neurol; 2008 Apr; 255(4):526-31. PubMed ID: 18202814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS.
    Geschwind MD; Skolasky RI; Royal WS; McArthur JC
    J Neurovirol; 2001 Aug; 7(4):353-7. PubMed ID: 11517416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive multifocal leukoencephalopathy successfully treated with highly active antiretroviral therapy and cidofovir in an adolescent infected with perinatal human immunodeficiency virus (HIV).
    Robinson LG; Chiriboga CA; Champion SE; Ainyette I; DiGrado M; Abrams EJ
    J Child Neurol; 2004 Jan; 19(1):35-8. PubMed ID: 15032381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cidofovir (vistide) in therapy of progressive multifocal leukoencephalopathy in AIDS. Review of the literature and report of 2 cases].
    Happe S; Besselmann M; Matheja P; Rickert CH; Schuierer G; Reichelt D; Husstedt IW
    Nervenarzt; 1999 Oct; 70(10):935-43. PubMed ID: 10554789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis.
    De Luca A; Ammassari A; Pezzotti P; Cinque P; Gasnault J; Berenguer J; Di Giambenedetto S; Cingolani A; Taoufik Y; Miralles P; Marra CM; Antinori A;
    AIDS; 2008 Sep; 22(14):1759-67. PubMed ID: 18753934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged survival in AIDS-related progressive multifocal leucoencephalopathy following anti-retroviral therapy and cidofovir.
    Roberts MT; Carmichael A; Lever AM
    Int J Antimicrob Agents; 2003 Apr; 21(4):347-9. PubMed ID: 12672581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy.
    Miralles P; Berenguer J; García de Viedma D; Padilla B; Cosin J; López-Bernaldo de Quirós JC; Muñoz L; Moreno S; Bouza E
    AIDS; 1998 Dec; 12(18):2467-72. PubMed ID: 9875585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cidofovir: progress in the treatment of progressive multifocal encephalopathy (PML)?
    Wilcox RD
    HIV Clin; 2002; 14(1):1-2. PubMed ID: 11833445
    [No Abstract]   [Full Text] [Related]  

  • 19. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Albrecht H; Hoffmann C; Degen O; Stoehr A; Plettenberg A; Mertenskötter T; Eggers C; Stellbrink HJ
    AIDS; 1998 Jul; 12(10):1149-54. PubMed ID: 9677163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era.
    Antinori A; Ammassari A; Giancola ML; Cingolani A; Grisetti S; Murri R; Alba L; Ciancio B; Soldani F; Larussa D; Ippolito G; De Luca A
    J Neurovirol; 2001 Aug; 7(4):323-8. PubMed ID: 11517411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.